PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT)

Citation
J. Nemunaitis et al., PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT), Blood, 82(10), 1993, pp. 10000286-10000286
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
82
Issue
10
Year of publication
1993
Supplement
1
Pages
10000286 - 10000286
Database
ISI
SICI code
0006-4971(1993)82:10<10000286:PDTOR(>2.0.ZU;2-1